Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection According to Baseline hCMV-specific T-cell Response in Kidney Transplant Patients (RESPECT)

NCT02550639 is registered in ClinicalTrials.gov with ORIOL BESTARD as lead sponsor.

NCT NCT02550639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02550639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection According to Baseline hCMV-specific T-cell Response in Kidney Transplant Patients (RESPECT)
Lead sponsor
ORIOL BESTARD
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
October 31, 2018
Enrollment
160 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cmv infection, kidney transplantation